Global Point-of-Care Infection Control Market Overview
Western Market Research estimates that the Global Point-of-Care Infection Control Market was valued at USD XXXX million in 2025 and is projected to reach USD XXXX million by 2036, expanding at a CAGR of XX% during the forecast period 2026–2036.
Point-of-care (POC) infection control solutions are designed to prevent cross-contamination at or near the patient site, encompassing skin antisepsis, environmental disinfection, device-related contamination control, and workflow-embedded safety tools. Market growth is driven by the rising burden of healthcare-associated infections (HAIs), stricter infection-prevention protocols, expansion of ambulatory and homecare services, and increasing adoption of rapid, user-friendly, and protocol-compliant solutions.
This study integrates primary research (infection-prevention specialists, hospital procurement teams, manufacturers) with secondary analysis (policy frameworks, standards, historical adoption). The assessment evaluates product efficacy, workflow integration, compliance, reimbursement dynamics, and regional adoption.
Impact of COVID-19 on the Point-of-Care Infection Control Market
COVID-19 accelerated adoption across all care settings due to heightened awareness of infection risks. Key impacts included:
-
Rapid uptake of skin antisepsis and surface disinfection at care points
-
Expansion of single-use and contamination-reducing devices
-
Sustained post-pandemic demand as protocols became institutionalized
While supply chains faced short-term pressure, long-term demand remained structurally higher.
Global Point-of-Care Infection Control Market Segmentation
By Product Type
-
Skin Sterilization & Antiseptics
-
Environmental Disinfection (Wipes, Sprays, UV/No-Touch Adjuncts)
-
Device-Associated Infection Prevention (Caps, Barriers, Closed Systems)
-
Hand Hygiene & PPE Adjuncts
-
Others
By Technology
-
Chemical-Based Disinfection
-
UV & Light-Based Disinfection (Adjunct)
-
Single-Use & Disposable Infection-Control Products
By Application
-
Hospitals
-
Clinics
-
Ambulatory Surgery Centers (ASCs)
-
Homecare & Long-Term Care Settings
By End User
-
Acute Care Facilities
-
Outpatient & Specialty Clinics
-
Homecare Providers
Regional Analysis
North America
-
Strong regulatory emphasis on HAI reduction
-
High adoption of device-associated infection prevention
-
Mature reimbursement and procurement frameworks
Europe
-
Standardized infection-control protocols
-
Growing use in outpatient and ambulatory settings
-
Focus on sustainability and compliance
Asia-Pacific
-
Fastest-growing region
-
Expanding healthcare infrastructure and outpatient care
-
Rising awareness of infection prevention at care points
South America
-
Gradual adoption supported by public health initiatives
-
Growth in private healthcare facilities
Middle East & Africa
-
Expansion led by tertiary hospitals and private care networks
-
Increasing investments in infection-control modernization
Competitive Landscape – Key Market Players
Competition is driven by efficacy, ease of use, compliance support, and integration into clinical workflows. Key players include:
-
3M
-
Premier
-
Stanley
-
SW Safety Solutions
-
Global Life Technologies
-
Magnolia Medical Technologies
-
Siemens Healthineers
-
Thermo Fisher Scientific
-
BD
-
STERIS
Porter’s Five Forces Analysis
-
Threat of New Entrants: Medium – regulatory and clinical validation required
-
Bargaining Power of Suppliers: Moderate – chemicals, disposables, and components
-
Bargaining Power of Buyers: High – hospital systems negotiate on value and outcomes
-
Threat of Substitutes: Low to Moderate – protocols require validated solutions
-
Competitive Rivalry: High – differentiation via outcomes data and workflow fit
SWOT Analysis
Strengths
-
Essential to patient safety and compliance
-
Broad applicability across care settings
-
Recurring demand driven by protocols
Weaknesses
-
Price sensitivity in cost-constrained settings
-
Training and compliance variability
Opportunities
-
Expansion in homecare and ASCs
-
Growth of single-use and device-associated prevention
-
Data-backed solutions demonstrating HAI reduction
Threats
-
Procurement consolidation and pricing pressure
-
Regulatory changes affecting chemical use
Trend Analysis
-
Shift toward device-associated infection prevention
-
Increased adoption of single-use and disposable products
-
Integration of infection-control tools into clinical workflows
-
Emphasis on outcomes-based purchasing
-
Growth in homecare-focused infection control
Market Drivers & Challenges
Key Drivers
-
Rising incidence and cost of HAIs
-
Stricter infection-prevention regulations
-
Growth of outpatient and home-based care
Key Challenges
-
Cost containment pressures
-
Ensuring consistent compliance and training
-
Environmental concerns around disposables
Value Chain Analysis
-
Raw Materials & Chemical Suppliers
-
Infection-Control Product Manufacturers
-
Distributors & GPOs
-
Hospitals, Clinics & Homecare Providers
-
Patients & Care Teams
Strategic Recommendations for Stakeholders
-
Manufacturers: Focus on workflow-embedded, evidence-backed solutions
-
Healthcare Providers: Prioritize products with measurable HAI reduction
-
Investors: Target device-associated prevention and homecare growth
-
Distributors: Expand education and compliance support services
-
Policy Makers: Encourage outcomes-based adoption and sustainability
1. Market Overview of Point Of Care Infection Control
1.1 Point Of Care Infection Control Market Overview
1.1.1 Point Of Care Infection Control Product Scope
1.1.2 Market Status and Outlook
1.2 Point Of Care Infection Control Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Point Of Care Infection Control Historic Market Size by Regions
1.4 Point Of Care Infection Control Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Point Of Care Infection Control Sales Market by Type
2.1 Global Point Of Care Infection Control Historic Market Size by Type
2.2 Global Point Of Care Infection Control Forecasted Market Size by Type
2.3 Skin Sterilization
2.4 Environmental Disinfection
2.5 Others
3. Covid-19 Impact Point Of Care Infection Control Sales Market by Application
3.1 Global Point Of Care Infection Control Historic Market Size by Application
3.2 Global Point Of Care Infection Control Forecasted Market Size by Application
3.3 Hospitals
3.4 Clinics
3.5 Homecare Settings
3.6 Ambulatory Surgery Centers
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Point Of Care Infection Control Production Capacity Market Share by Manufacturers
4.2 Global Point Of Care Infection Control Revenue Market Share by Manufacturers
4.3 Global Point Of Care Infection Control Average Price by Manufacturers
5. Company Profiles and Key Figures in Point Of Care Infection Control Business
5.1 3M
5.1.1 3M Company Profile
5.1.2 3M Point Of Care Infection Control Product Specification
5.1.3 3M Point Of Care Infection Control Production Capacity, Revenue, Price and Gross Margin
5.2 Premier
5.2.1 Premier Company Profile
5.2.2 Premier Point Of Care Infection Control Product Specification
5.2.3 Premier Point Of Care Infection Control Production Capacity, Revenue, Price and Gross Margin
5.3 Stanley
5.3.1 Stanley Company Profile
5.3.2 Stanley Point Of Care Infection Control Product Specification
5.3.3 Stanley Point Of Care Infection Control Production Capacity, Revenue, Price and Gross Margin
5.4 SW Safety Solutions
5.4.1 SW Safety Solutions Company Profile
5.4.2 SW Safety Solutions Point Of Care Infection Control Product Specification
5.4.3 SW Safety Solutions Point Of Care Infection Control Production Capacity, Revenue, Price and Gross Margin
5.5 Global Life Technologies
5.5.1 Global Life Technologies Company Profile
5.5.2 Global Life Technologies Point Of Care Infection Control Product Specification
5.5.3 Global Life Technologies Point Of Care Infection Control Production Capacity, Revenue, Price and Gross Margin
5.6 Magnolia Medical Technologies
5.6.1 Magnolia Medical Technologies Company Profile
5.6.2 Magnolia Medical Technologies Point Of Care Infection Control Product Specification
5.6.3 Magnolia Medical Technologies Point Of Care Infection Control Production Capacity, Revenue, Price and Gross Margin
5.7 Siemens
5.7.1 Siemens Company Profile
5.7.2 Siemens Point Of Care Infection Control Product Specification
5.7.3 Siemens Point Of Care Infection Control Production Capacity, Revenue, Price and Gross Margin
5.8 Thermo Fisher Scientific
5.8.1 Thermo Fisher Scientific Company Profile
5.8.2 Thermo Fisher Scientific Point Of Care Infection Control Product Specification
5.8.3 Thermo Fisher Scientific Point Of Care Infection Control Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Point Of Care Infection Control Market Size
6.2 North America Point Of Care Infection Control Key Players in North America
6.3 North America Point Of Care Infection Control Market Size by Type
6.4 North America Point Of Care Infection Control Market Size by Application
7. East Asia
7.1 East Asia Point Of Care Infection Control Market Size
7.2 East Asia Point Of Care Infection Control Key Players in North America
7.3 East Asia Point Of Care Infection Control Market Size by Type
7.4 East Asia Point Of Care Infection Control Market Size by Application
8. Europe
8.1 Europe Point Of Care Infection Control Market Size
8.2 Europe Point Of Care Infection Control Key Players in North America
8.3 Europe Point Of Care Infection Control Market Size by Type
8.4 Europe Point Of Care Infection Control Market Size by Application
9. South Asia
9.1 South Asia Point Of Care Infection Control Market Size
9.2 South Asia Point Of Care Infection Control Key Players in North America
9.3 South Asia Point Of Care Infection Control Market Size by Type
9.4 South Asia Point Of Care Infection Control Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Point Of Care Infection Control Market Size
10.2 Southeast Asia Point Of Care Infection Control Key Players in North America
10.3 Southeast Asia Point Of Care Infection Control Market Size by Type
10.4 Southeast Asia Point Of Care Infection Control Market Size by Application
11. Middle East
11.1 Middle East Point Of Care Infection Control Market Size
11.2 Middle East Point Of Care Infection Control Key Players in North America
11.3 Middle East Point Of Care Infection Control Market Size by Type
11.4 Middle East Point Of Care Infection Control Market Size by Application
12. Africa
12.1 Africa Point Of Care Infection Control Market Size
12.2 Africa Point Of Care Infection Control Key Players in North America
12.3 Africa Point Of Care Infection Control Market Size by Type
12.4 Africa Point Of Care Infection Control Market Size by Application
13. Oceania
13.1 Oceania Point Of Care Infection Control Market Size
13.2 Oceania Point Of Care Infection Control Key Players in North America
13.3 Oceania Point Of Care Infection Control Market Size by Type
13.4 Oceania Point Of Care Infection Control Market Size by Application
14. South America
14.1 South America Point Of Care Infection Control Market Size
14.2 South America Point Of Care Infection Control Key Players in North America
14.3 South America Point Of Care Infection Control Market Size by Type
14.4 South America Point Of Care Infection Control Market Size by Application
15. Rest of the World
15.1 Rest of the World Point Of Care Infection Control Market Size
15.2 Rest of the World Point Of Care Infection Control Key Players in North America
15.3 Rest of the World Point Of Care Infection Control Market Size by Type
15.4 Rest of the World Point Of Care Infection Control Market Size by Application
16 Point Of Care Infection Control Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter
Global Point-of-Care Infection Control Market Segmentation
By Product Type
-
Skin Sterilization & Antiseptics
-
Environmental Disinfection (Wipes, Sprays, UV/No-Touch Adjuncts)
-
Device-Associated Infection Prevention (Caps, Barriers, Closed Systems)
-
Hand Hygiene & PPE Adjuncts
-
Others
By Technology
-
Chemical-Based Disinfection
-
UV & Light-Based Disinfection (Adjunct)
-
Single-Use & Disposable Infection-Control Products
By Application
-
Hospitals
-
Clinics
-
Ambulatory Surgery Centers (ASCs)
-
Homecare & Long-Term Care Settings
By End User
-
Acute Care Facilities
-
Outpatient & Specialty Clinics
-
Homecare Providers
Competitive Landscape – Key Market Players
Competition is driven by efficacy, ease of use, compliance support, and integration into clinical workflows. Key players include:
-
3M
-
Premier
-
Stanley
-
SW Safety Solutions
-
Global Life Technologies
-
Magnolia Medical Technologies
-
Siemens Healthineers
-
Thermo Fisher Scientific
-
BD
-
STERIS
